Strong M&A momentum in 2026, with global deal value tracking toward $4-5 trillion amid a surge in megadeals over $5 billion, reflects corporate and private equity focus on scale in AI infrastructure, healthcare, energy, and digital transformation. Elevated interest rates—following limited Fed easing—and persistent inflation around 3.8% earlier in the year continue to influence financing costs and buyer selectivity, while stabilizing regulatory reviews have shortened some approval timelines. Pending transactions in media, rail, utilities, and biotech face antitrust and shareholder hurdles that could delay closings into 2027, though carve-outs and mid-market activity show resilience. Key near-term catalysts include FOMC policy updates, earnings releases, and regulatory milestones for announced deals. Trader sentiment aggregates real-capital views on which targets clear these thresholds before year-end.